Published 2 months ago • loading... • Updated 2 months ago

AstraZeneca scraps £450m vaccine plant in Liverpool after Labour funding cut

AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool due to a cut in funding from the government, as stated by the pharmaceutical giant.
The investment was initially announced as a 'vote of confidence' in Liverpool and the UK's life science sector, but Labour ministers offered less funding than before.
An AstraZeneca spokesperson noted that 'Several factors have influenced this decision including the timing and reduction of the final offer compared to the previous government's proposal.'
The government stated that a 'change in the make-up of the investment' led to a reduced grant offer, highlighting the need for taxpayer value.

Insights by Ground AI

Does this summary seem wrong?

40 Articles

All

Left

Center

Right

Channel 4

Lean Left

Astrazeneca cancels million-pound investment in UK vaccine factory

The pharmaceutical giant AstraZeneca has cancelled plans to invest £450 million in a vaccine manufacturing plant in Merseyside – blaming the Labour for failing to match the level of funding offered by the previous government.

2 months ago·London, United Kingdom

Read Full Article

Toronto Sun

Right

AstraZeneca scraps plan to expand vaccine plant in U.K. in blow to government

Pharmaceutical company AstraZeneca cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in northwest England

2 months ago·Toronto, Canada

Read Full Article

Bloomberg

Reposted by

Financial Post

Lean Left

AstraZeneca Calls Off Vaccine Hub Investment Over UK Funding

AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following protracted wrangling with the new Labour government over the level of state funding for the site.

2 months ago·United States

Read Full Article

Reuters

Center

AstraZeneca ditches UK investment over cut in state support

AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in northern England, citing a cut in British government support.

2 months ago·United Kingdom

Read Full Article